TIG Advisors LLC’s Apellis Pharmaceuticals APLS Stock Holding History

TIG Advisors LLC’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,252,986	Closed	-$50.4M	–	112
2026 Q1	$50.4M	Buy	+1,252,986	New	+$27M	2.33%	12
2024 Q1	–	Sell	-17,093	Closed	-$1.02M	–	52
2023 Q4	$1.02M	Buy	+17,093	New	+$867K	0.13%	41

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TIG Advisors LLC's APLS Position: Q2 2026 in Review

TIG Advisors LLC sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 1,252,986 shares — an estimated $50.4M sold.

TIG Advisors LLC first reported a position in APLS in Q4 2023 and held it in 2 quarters. The position peaked at $50.4M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

TIG Advisors LLC reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
TIG Advisors LLC sold 1,252,986 Apellis Pharmaceuticals shares in Q2 2026, an estimated $50.4M.
TIG Advisors LLC first reported a position in Apellis Pharmaceuticals in Q4 2023 and held it in 2 quarters.
TIG Advisors LLC's Apellis Pharmaceuticals position peaked at $50.4M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on TIG Advisors LLC's 13F filing for Q2 2026, filed 14 Aug 2026.